Delivery and formulation of engineered nucleic acids
AssigneeModerna Therapeutics, Inc.
InventorsJason P. Schrum, Noubar B. Afeyan, Gregory J. Sieczkiewicz, Stephane Bancel, Antonin de Fougerolles, Sayda M. Elbashir
Life of this patent
Estimating the term…
Abstract
Provided are formulations, compositions and methods for delivering biological moieties such as modified nucleic acids into cells to modulate protein expression. Such compositions and methods include the delivery of biological moieties, and are useful for production of proteins.
Claims26
A method of producing a polypeptide of interest in a cell, tissue or bodily fluid of a mammalian subject in need thereof comprising administering to said subject a pharmaceutical composition comprising a polynucleotide, said polynucleotide comprising a sequence selected from the group consisting of SEQ ID NO:
- 4, 7, 8 and 12.
An isolated polynucleotide, said polynucleotide comprising a sequence selected from the group consisting of SEQ ID NO:
- 4, 7, 8 and 12.
Dependencies are inferred from the claim text.